Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Boston Scientific Buys Claret Medical
The deals keep coming from Boston Scientific Corp. (NYSE: BSX). The medical device maker announced its sixth deal so far this year on July 20. The latest target is privately held Claret Medical, Inc., based in Santa Rosa, California. Claret developed and commercialized the Sentinel Cerebral Embolic Protection System, which is used to protect the brain during certain interventional procedures, primarily during transcatheter aortic valve (TAV) replacement. It is the only device to protect patients against the risk of stroke. The Sentinel System received CE Mark in 2014 and FDA clearance in 2017. Boston Scientific agreed to pay $220 million in cash, as well as a potential reimbursement-based... Read More »
Physician Practices Kept Consolidating in Q2:18
Investor interest in physician medical groups ramped up significantly in 2018, with 55 transactions announced in the first quarter, followed by 53 deals in the second quarter. The second quarter deals represent 29% of the total of 184 announced in the previous 12 months. Deal volume slipped 4% compared with the previous quarter but posted a 61% increase versus the same quarter a year earlier. Physicians in small practices have been under growing pressure from regulations and legislation, changes in reimbursement cycles and episodes of care. Under MACRA, they may be the lead provider when it comes to bundled payments, which makes primary care and hospital-based physicians of interest to... Read More »
Healthcare Deal Volume Rose 8% in Q2:18
With 462 deals announced in the second quarter, healthcare deal volume was up 8% compared with the 427 transactions announced in the previous quarter, according to our Deal Search Online database. Deal volume was higher than the same quarter in 2017, up 21%% compared with the 383 deals reported then. Healthcare deal volume in the last two quarters has grown stronger, with both quarters in 2018 rising above 425 deals. Heavy deal volume has become the “new normal,” and judging by the most recent five quarters, the lower range begins around 380 transactions per quarter. Deal volume in the health care services category, at 285 transactions, was up 4% from the previous quarter. Services deals... Read More »
Health Care M&A Deals, Week Ending July 13, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price Civitas Solutions, Inc. Creative Connections, Inc. n/a Biotechnology Acquirer Target Price Biodesix, Inc. Integrated Diagnostics, Inc. n/a Axovant Sciences Ltd. Global rights to BB-301 $10... Read More »
Behavioral Health Deals Set a Strong Pace in H1:18
The Behavioral Health Care sector has been on a hot streak for more than three years now. In 2018, the pace may be picking up even more. In the first half of the year, 34 transactions were announced, compared with 29 in the first half of 2017. Prices for these deals, which are primarily between private equity firms and/or not-for-profit entities, are scarce. Only one deal in this sector disclosed a price so far this year, an approximately $108 million transaction in South Africa, for privately held Akeso Clinics. Netcare Limited, the second largest private hospital company in South Africa, was the buyer. In both years, companies that treated substance abuse disorders were most popular with... Read More »
Specialty CROs Are the Latest Trend in Services Targets
Contract research organizations (CROs) were huge targets in 2017, with four of the sector’s 10 biggest deals bringing in $22.9 billion, combined. The CRO market has cooled in 2018, but interesting new trends pop up now and then. The latest is the trend toward specialty CROs, which focus on specific areas such as diseases of the central nervous system. In one week in July, two such CROs have traded hands. The first, on July 9, was Oculos Clinical Research, a CRO based in Tampa, Florida that focuses on ophthalmology. Private equity firm Point Guard Partners was exiting, and Iuvo Bioscience, a portfolio company of Tartan Holdings, was investing. Iuvo Bioscience, based in Rush, New... Read More »
Otsuka Scores Twice in One Week
Otsuka Pharmaceutical Co., Ltd., a subsidiary of Otsuka Holdings (OTC: OTSKY), announced back-to-back deals in early July, in which it entered a new field, and bolstered one of its existing segments. Otsuka’s research areas are in psychiatric and neurological diseases, hematological cancers, and kidney, cardiovascular, and infectious diseases. On July 11, the company announced its acquisition of ReCor Medical, a portfolio company of Sofinnova Partners, for an undisclosed price. The Palo Alto, California-based medical device company specializes in the treatment of hypertension, a new area for Otsuka. ReCor was founded in 2009 by Sofinnova Partners and Professor Jacques Seguin, MD, who... Read More »
Health Care M&A Weekly Deals, Week Ending July 6, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Hospitals Acquirer Target Price ApolloMed Holdings and AMHC Healthcare The French Hospital $33 million Long-Term Care Acquirer Target Price Griffin-American Healthcare REIT IV Pelican Bay Assisted Living & Memory Care $19.5 million... Read More »
Q2:18 Health Care Deal Volume and Value Explode
What a quarter it was. Even with preliminary data, the numbers of deals and dollars spent in the second quarter of 2018 are impressive. The quarter began with a bang in April (176 deals), settled in May (136 deals) and slowed in June (122 deals). That still adds up to 432 transactions reported in the second quarter, up 1% compared with the first quarter, and 13% better than the same quarter in 2017. The Services sectors accounted for 59% of the deal volume in Q1:18, five percentage points lower than in the previous quarter, and three percentage points lower than Q2:17. The Long-Term Care sector, which turned in 47 deals in April alone, posted gains of 28% compared with Q1:18 and 33%... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
